Chinese Vaccine

2021.12.22

11:54

China's WestVac vaccine against Omicron to enter clinical trials in early 2022

Asian Tech Press (Dec 22) -- Chinese vaccine maker WestVac Biopharma Co., Ltd. announced Monday that its second-generation COVID-19 vaccine has high titers of neutralizing antibodies against the Omicron variant, and is expected to enter clinical trials in early 2022.

2021.10.01

13:40

Australia announces China's Sinovac vaccine as a 'recognised vaccine'

Asian Tech Press (Oct 1) -- Australia's drug regulator announced Friday that China's Sinovac vaccine is a "recognised vaccine".

2021.09.27

08:03

Malaysia study: China's Sinovac vaccine highly effective against serious illness

Asian Tech Press (Sep 27) -- A large real world study in Malaysia shows that China's Sinovac COVID-19 vaccine is also highly effective against serious illness, although vaccines from Pfizer/BioNTech and AstraZeneca have shown better protection efficiency, Reuters reported last Friday.

2021.09.22

08:27

Chinese mRNA COVID-19 vaccine approved for Phase III clinical trial in Nepal

Asian Tech Press (Sep 22) -- China-based firm Walvax Biotechnology Co., Ltd. (Walvax) announced Wednesday that its mRNA COVID-19 vaccine has been approved for Phase III clinical trial in Nepal.

2021.09.14

11:24

Japan launches first-ever clinical trials on Chinese COVID-19 vaccine

Asian Tech Press (Sep 14) -- A research team led by Nagasaki University has begun clinical trials in Japan for a COVID-19 recombinant vaccine developed by China's Sichuan University, NHK reported Tuesday.

2021.08.17

08:26

Argentina finds China's Sinopharm COVID vaccine 84% effective in preventing death

The Argentine Ministry of Health has released a report announcing data on the incidence of adverse reactions to China's Sinopharm Covid-19 vaccine in Argentina and the vaccine's effectiveness in preventing death in people aged over 60.

2021.08.06

07:59

Sinovac to file for EUA for its COVID-19 vaccine against Delta variant in countries

Asian Tech Press -- Yin Weidong, chairman and CEO of Sinovac Biotech Ltd (SVA: NASDAQ GS), said in a speech at the first International Forum on Vaccine Cooperation on August 5, that Sinovac will soon submit applications to national drug regulatory authorities in several countries for clinical studies and Emergency Use Authorization (EUA) of its COVID-19 vaccines against Gamma and Delta variants.

2021.08.05

08:41

China's Sinovac effective against Gamma variant, Brazil study says

The Butantan Institute, a leading medical research institute in Brazil, recently released the results of a study showing that the Chinese Sinovac Covid-19 vaccine can help protect people over 70 years of age effectively against the Gamma Covid-19 variant.

2021.08.04

04:31

Sinovac's COVID-19 vaccine was 58.5% effective, Chilean health authorities say

SANTIAGO, Aug 3 (Reuters) - Sinovac's COVID-19 vaccine was 58.5% effective in preventing symptomatic illness among millions of Chileans who received it between February and July, the Chilean health authorities said on Tuesday, while Pfizer's COVID-19 shot was 87.7% effective and AstraZeneca's was 68.7% effective.

2021.07.29

06:17

CanSinoBIO's inhaled COVID-19 vaccine shows good safety in phase 1 clinical trial

Asian Tech Press -- CanSinoBIO's inhaled COVID-19 vaccine Ad5-nCo, also known as Convidecia, has proven to have good safety in phase 1 clinical trial, according to a recent research published in The Lancet.

2021.07.02

09:14

China's Foreign Ministry: Over 100 countries approved the use of Chinese vaccines

Wang Wenbin, the spokesperson of Ministry of Foreign Affairs, said that since the epidemic outbreak, China has firmly upheld the "first attribute" of vaccines as a global public product.

2021.06.29

12:00

Indonesia approves China's Sinovac shot for ages 12 to 17

(Asian Tech Press) Indonesia has approved China's Sinovac shot for ages 12 to 17, according to Indonesian media reports.

2021.06.07

13:00

China's Sinovac gets nod for over 3 years old in Thailand

China’s Sinovac vaccine has been approved by Thailand for COVID-19 jabs for people over 3 years old.

2021.05.27

04:24

WHO may delay emergency use approval for China's Sinovac vaccine

According to The Wall Street Journal, WHO may delay emergency use approval for China's Sinovac vaccine.

2021.05.19

11:00

Chinese vaccine remains protective against mutated strains in South Africa, UK, & Brazil

Shao Yiming, a researcher at the Chinese CDC and member of the expert panel of the R&D task force on vaccines in the scientific research and development group, says:

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Tencent Holdings repurchased 3.93 million shares for HK$1.5 billion on January 7
                            2025-01-07

                                    Ireland recorded a 12.8 billion euro fiscal surplus last year due to the "Apple tax" ruling
                            2025-01-07

                                    Ministry of Industry and Information Technology: Promoting technical verification of 10G optical network and artificial intelligence integration
                            2025-01-07

                                    Tencent's major shareholder Prosus reduced its stake in Tencent Holdings from 24.01% to 23.99% on January 6.
                            2025-01-07

                                    U.S. chip stocks rose before the market opened, with Nvidia up 0.6%
                            2025-01-07